Board of Directors - BICO - We create the future of health

Board of Directors

Carsten Browall
Born 1958. Chairman since 2019 and member of the board since 2018. Chairman of the Remuneration Committee and member of the Audit Committee.

Education and work experience:
M.Sc. in economics from the University of Gothenburg.  Professional board work. Extensive experience of the medical de-vice and healthcare sectors in fast-growing companies such as Mölnlycke, Nobel Bio-care, Capio, Vitrolife and Unfors RaySafe.

Other assignments and positions:
Chairman of GHP Speciality Care AB (publ), board member of Bure Equity AB, and CEO of Carbo AB.

Shareholding in BICO:
Options: 160,000

Independent in relation to the company and group management and to the company’s major shareholders.

Erik Gatenholm
Born 1989. Board member and CEO since 2016.

Education and work experience:
B.Sc. at Virginia Tech University and an MBA from Gothenburg University. Erik has documented success in biotechnology entrepreneurship with more than 13 years of entrepreneurial experience. Honors include: Forbes 30 Under 30, MIT Review 35 Under 35, and Entrepreneur of the year 2020.

Other assignments and positions:
Board member of BICO group AB and chairman of CELLINK Options AB.

Shareholding in BICO:
A-aktier: 848,958, B-aktier: 8,668,036. Ownership: 16.50%, Voting right: 24.11%

Dependent in relation to the company and group management and to the company’s major shareholders.

Helena Skåntorp
Born 1960. Board member since 2019. Chairman of the Audit Committee.

Education and work experience:
Long experience from leading positions as CEO and CFO, for example for Jarowskij AB and Arla, and Doctoral student at Stockholm School of Economics. She has been a member of boards of listed companies for more than 15 years.

Other assignments and positions:
Chairman of Nielstorp AB, Plint AB and Ljung & Sjöberg AB. Board member of ByggPartner i Dalarna AB, ByggPartner i Dalarna Holding AB (publ) and Mekonomen AB (publ).

Shareholding in BICO:
B-aktier: 4,000, Options: 40,000

Independent in relation to the company and group management and to the company’s major shareholders.

Bengt Sjöholm
Born 1953. Board member since 2016. Member of the Remuneration Committee and the Audit Committee.

Education and work experience:
M.Sc. in electrical engineering from Lund University of Technology. He has been CEO of several Swedish companies such as Tylö and CEO of one of the business areas within the Getinge Group.

Other assignments and positions:
Chairman and CEO of BSJ i Halmstad AB and board member of Avidicare Holding AB, Integrum AB, Handelstriangeln AB, Mentice Ab and Texor AB.

Shareholding in BICO:
B-aktier: 268,276, Options: 20,000, Ownership: 0.47%, Voting right: 0.38%

Independent in relation to the company and group management and to the company’s major shareholders.

Christian Wildmoser
Born 1955. Board member since 2019. Member of the Renumeration Committee.

Education and work experience:
Doctor of Economics and has worked in banking for 25 years. He has been a partner of CVC Capital Partners for 16 years with responsibility for the operations in German-speaking Europe. Today, he is a private investor in growth companies.

Other assignments and positions:
Chairman of Waterdrop Microdrinks GmbH, board member of 1Drop SA, and Board of the African Parks Foundation Switzerland.

Shareholding in BICO:
B-aktier: 318,492, Options: 40,000
Ownership: 0.55%, Voting right: 0.44%

Independent in relation to the company and group management and to the company’s major shareholders.

Aristotelis Nastos
Born 1967. Board member since 2020.

Education and work experience:
Ph.D. in Molecular and Cell Biology. He has more than 20 years of experience from the European VC Industry with a broad network and deep insight in the global Life Science and financing industry.

Other assignments and positions:
Head of Life Sciences & Cleantech at NRW.BANK, board member of Abalos Therapeutics GmbH, Fasciotens GmbH, Emergence Therapeutics AG and Resolve Biosciences GmbH and member of Board of Directors of AYOXXA Biosystems GmbH, CEVEC Pharmaceuticals GmbH and Cryotherapeutics GmbH.

Shareholding in BICO: –

Independent in relation to the company and group management and to the company’s major shareholders.

Shareholding in BICO per August 31, 2021.